OCTOBER 25-26, 2018
WORLD ANTI-MICROBIAL RESISTANCE CONGRESS, WASHINGTON DC, USA
Dr. Gitzinger will be speaking October 26th at 14:00 at the Congress in Washington, DC.
The Title: Composite endpoints – the way to FDA approval for non-traditional antibiotics requires new thinking around endpoints in clinical trials. Are composite endpoints a way forward?
The Agenda can be seen at this link. The Conference will be addressing 4 key areas:
- Antibiotic R&D
- Antimicrobial Stewardship
- Innovation Showcase
OCTOBER 17-20, 2018
21ST-CENTURY DRUG DISCOVERY & DEVELOPMENT FOR GLOBAL HEALTH
Please join us at the Keystone Symposia in Berlin where Marc Gitzinger will be speaking. See http://www.keystonesymposia.org/18S3 for more details.
SEPTEMBER 2TH-7TH, 2018
ESCMID/ASM CONFERENCE ON DRUG DEVELOPMENT
The ESCMID/ASM Conference on Drug Development to meet the chanllenge of antimicrobial resistance will be held in Lisbon, Portugal this year. Dr. Gitzinger will be attending.
The event information can be found here